In vitro study of stromal cell defects in myelodysplastic syndromes

Haematologica

Volumn 88, Issue 7, 2003, Pages 827-829

  Boudard, Delphine ^a   Viallet, Annie ^b   Piselli, Simone ^a   Guyotat, Denis ^a   Campos, Lydia ^a  

^a UNIVERSITÉ JEAN MONNET   (France)

^b Laboratoire Mort Cell et Neoplasies ^*

Author keywords

Caspase 3; Myelodysplastic syndromes; Stromal cells; VEGF

Indexed keywords

CASPASE 3; CD31 ANTIGEN; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; APOPTOSIS; ARTICLE; BONE MARROW CULTURE; CELL CULTURE; CHRONIC MYELOMONOCYTIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMATOPOIESIS; HEMATOPOIETIC CELL; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MALE; MYELODYSPLASTIC SYNDROME; PROTEIN EXPRESSION; REFRACTORY ANEMIA; SIDEROBLASTIC ANEMIA; STAINING; STROMA CELL;

ADULT; AGED; ANTIGENS, CD31; CASPASE 3; CASPASES; CELL DIVISION; CELLS, CULTURED; CYTOKINES; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; STROMAL CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0037700675     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Yoshida Y. Hypothesis: apoptosis may be the mechanism responsible for the premature intramedullary cell death in the myelodysplastic syndrome. Leukemia 1993;7:144-6.
2. Elstner E, Wachter M, Ihle R. Bone marrow stromal cells in myelodysplastic syndromes and acute nonlymphocytic leukemia. Hamatol Bluttransfus 1989;32:168-71.
3. Raza A, Gezer S, Mundle S, Gao XZ, Alvi S, Borok R, et al. Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood 1995;86:268-76.
4. Manakova T, Gerasimova L, Tsvetaeva N, Momotyuk K. Functional disturbances in hemopoietic microenvironment in various forms of myelodysplastic syndrome. Bull Exp Biol Med 2000;130:832-4.
5. Tennant GB, Walsh V, Truran LN, Edwards P, Mills KI, Burnett AK Abnormalities of adherent layers grown from bone marrow of patients with myelodysplasia. Br J Haematol 2000;111:853-62.
6. Boudard D, Sordet O, Vasselon C, Revol V, Bertheas MF, Freyssenet D, et al. Expression and activity of caspases 1 and 3 in myelodysplastic syndromes. Leukemia 2000;14: 2045-51.
7. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982;51: 189-99.
8. Agematsu K, Nakahori Y. Recipient origin of bone marrow-derived fibroblastic stromal cells during all periods following bone marrow transplantation in humans. Br J Haematol 1991;79:359-65.
9. Dexter TM, Allen TD, Lajtha LG. Conditions controlling the proliferation of haemopoietic stem cells in vitro. J Cell Physiol 1977;91:335-44.
10. Thuret G, Chiquet C, Herrag S, Dumollard JM, Boudard D, Bednarz J, et al. Mechanisms of staurosporine induced apoptosis in human corneal endothelial cell line. Br J Ophthalmol 2003;87:346-52.